ESR1 and breast cancer: In our laboratory, we have established a cellular model of EMT in breast cancer cells which developed in parallel with endocrine resistance induced by blockade of estrogen receptor (ER)-α mRNA translation in the parental MCF-7 cells using ER-directed shRNA transfection.